Altered fibrin clot properties in patients with premature peripheral artery disease

Agnieszka Okraska-Bylica1, Tadeusz Wilkosz, Lidia Słowik

  • 1Department of Diagnostics, John Paul II Hospital, Kraków, Poland. aokraska@szpitaljp2.krakow.pl

Insights

Peripheral artery disease (PAD) patients, both premature and older, exhibit abnormal fibrin clot formation. Premature PAD independently predicts clot permeability and absorbance, highlighting its thrombotic risk.

Area of Science:

  • Vascular Biology
  • Thrombosis Research
  • Clinical Medicine

Background:

  • Elderly patients with peripheral artery disease (PAD) often display denser, poorly lysable fibrin clots.
  • This study investigates whether premature PAD is linked to a more prothrombotic fibrin clot phenotype.

Purpose of the Study:

  • To test the hypothesis that premature PAD is associated with a more prothrombotic fibrin clot phenotype.
  • To compare fibrin clot characteristics between premature PAD, older PAD patients, and controls.

Main Methods:

  • Ex-vivo analysis of plasma fibrin clot permeability, turbidity, and lysis time.
  • Study included 31 premature PAD patients (age ≤55), 32 older PAD patients (age >55), and 40 age/sex-matched controls.
  • Ankle-brachial index (ABI) was used to assess PAD severity.

Main Results:

  • Premature PAD patients showed significantly lower clot permeability (Ks), longer clot lysis time (t50%), and higher maximum D-dimer levels (D-Dmax) compared to controls.
  • These differences persisted after adjusting for risk factors and medications.
  • No significant differences in fibrin clot parameters were observed between premature and older PAD patients.

Conclusions:

  • Plasma fibrin clots exhibit a similarly abnormal prothrombotic phenotype in both premature and older PAD patients.
  • Factors influencing fibrin clot parameters differ between premature and older PAD groups.
  • Premature PAD was identified as an independent predictor of clot permeability and maximum fibrin gel absorbance.
Abstract

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...